AY
Aytu BioPharma, Inc.
AYTU · NASDAQ
$2.19 -1.35% (-$0.03)
1M -7.98%
Market Cap $24.5M
P/E Ratio -
Div. Yield -
ROE 148.91%
Piotroski F-Score Weak
3/9Valuation
93 /100
Cheap P/S 0.43x
P/FCF 14.92x
P/B 0.70x
Growth
0 /100
Declining Rev. growth 11.78%
Book val. growth 24.64%
EPS growth N/A
Profitability
27 /100
Weak Gross margin 62.50%
FCF margin 2.90%
Net margin 60.17%
Quality
6 /100
Poor ROIC 23.93%
Asset turnover 0.51x
ROE 148.91%
Debt
44 /100
Moderate Debt/Equity 0.65x
Int. coverage -14.02x
Current ratio 1.12x
Stability
33 /100
Unstable Beta 0.26x
Profitable years 0
Rev. volatility 26.83%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AYTU
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Joshua R. Disbrow
Employees
83
Headquarters
Denver
Upcoming events
22 SEP
Earnings
Upcoming earnings report
29 SEP
Earnings
Upcoming earnings report